Given the continuing development of new statins and their increasing beneficial use in clinical practice as well as the importance of clinical research into the atherosclerotic plaque and its role in cardiovascular and endovascular diseases, Gaw and Shepherd have chosen topics on lipids and atherosc
Lipids and Atherosclerosis
β Scribed by Chris J. Packard (Author); Daniel J. Rader (Author)
- Publisher
- CRC Press
- Year
- 2005
- Leaves
- 253
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
New discoveries in genetics, molecular, and cell biology are not only enhancing our understanding of the etiology and progression of disease, but are finding applications in the development of new drugs or the implementation of new kinds of therapy. This book provides an in-depth review of emerging areas in biomedical research at the interface of s
β¦ Table of Contents
List of contributors vii
Foreword xi
Preface xiii
Acknowledgements xiv
1. The assembly of very low density lipoproteins in the liver 1
S-O. Olofsson and L. Asp
2. Cardiovascular implications of partial, tissue-specific silencing of MTP 15
C.C. Shoulders
3. Acyl CoA: Diacylglycerol acyltransferases (DGATs) as therapeutic targets
for cardiovascular disease 31
J.S. Millar and J.T. Billheimer
4. The biochemical and physiological roles of ACAT1 and ACAT2 in
cholesterol homeostasis and atherosclerosis 41
R.G. Lee and L.L. Rudel
5. Overview of intestinal lipid metabolism 55
T.A. Miettinen and H. Gylling
6. The role of non-cholesterol sterols in the pathogenesis of atherosclerosis
and their modulation by the sitosterolaemia locus 63
E.L. Klett and S.B. Patel
7. FXR: the molecular link between bile acid and lipid metabolism 69
T. Claudel, E. Sturm, B. Staels and F. Kuipers
8. Overview of HDL and reverse cholesterol transport 81
P. Barter
9. LXR as a therapeutic target for atherosclerosis 93
I.G. Schulman and R.A. Heyman
10. Endothelial lipase and the regulation of HDL metabolism 101
K.O. Badellino and W. Jin
11. Cholesteryl ester transfer protein (CETP) inhibition as a therapeutic
strategy for raising HDL-cholesterol levels and reducing atherosclerosis 111
D.J. Rader
Contents
Prelims 14/7/05 4:44 pm Page v
12. Overview of insulin resistance and the metabolic syndrome 119
N. Sattar and B. Mukhopadhyay
13. Peroxisome proliferator activated receptors and energy metabolism 137
P. Gervois, J-C. Fruchart and B. Staels
14. Adipocytes and their secretory products 153
J.B. Prins
15. Regulation of adipocyte triglyceride storage 165
F. Karpe and G.D. Tan
16. Role of innate immunity in atherosclerosis: immune recognition,
immune activation and the atherosclerotic process 175
J-M. FernΓ‘ndez-Real
17. Role of CD44 in atherogenesis and its potential role as a therapeutic target 191
E. PurΓ©
18. Lipoxygenases: potential therapeutic target in atherosclerosis 207
L. Zhao and C.D. Funk
19. Role of secretory phospholipase A2 isozymes (Lp-PLA2) 219
C.H. Macphee
Index
β¦ Subjects
Bioscience;Biochemistry;Medicine, Dentistry, Nursing & Allied Health;Medicine;Pathology
π SIMILAR VOLUMES
<p>This volume comprises the proceedings of the sixth International Symposium on Drugs Affecting Lipid MetaΒ bolism. Since the first of these symposia in 1960 these triennial meetings have been devoted to the exploration of new ideas, new data and new concepts related to lipid metabolism and atheros
Given the continuing development of new statins and their increasing, beneficial use in clinical practice and given the importance of clinical research into the atherosclerotic plaque and its role in cardiovascular and endovascular diseases, given the immense advances in animal and human studies tha
<p>A unique overview of all major angiographic lipid intervention trials, presented by their principal investigators. Basic mechanisms and methodological aspects, including biochemical as well as angiographic aspects, are discussed by experts in these fields. A careful comparison of all available da